U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C6H4O7.C5H14NO.Fe.3H2O
Molecular Weight 402.153
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of FERROCHOLINATE

SMILES

O.O.O.[Fe+3].C[N+](C)(C)CCO.[O-]C(=O)CC([O-])(CC([O-])=O)C([O-])=O

InChI

InChIKey=UQSASSBWRKBREL-UHFFFAOYSA-K
InChI=1S/C6H7O7.C5H14NO.Fe.3H2O/c7-3(8)1-6(13,5(11)12)2-4(9)10;1-6(2,3)4-5-7;;;;/h1-2H2,(H,7,8)(H,9,10)(H,11,12);7H,4-5H2,1-3H3;;3*1H2/q-1;+1;+3;;;/p-3

HIDE SMILES / InChI

Description
Curator's Comment: description was created based on several sources, including: http://www.druginfosys.com/drug.aspx?drugcode=1316&type=1 | http://www.vademecum.es/medicamento-podertonic+adultos_3181

Ferrocholinate is a chelate prepared by reacting equal quantities of freshly precipitated ferric chloride with choline dihydrogen citrate. Ferrocholinate is used as a source of iron in iron deficiency anemia. Ferrocholinate absorption is increased by simultaneous administration of ascorbic acid. Absorption reduced by antacids, cholestyramine or proton pump inhibitors (omeprazole, pantoprazole, lansoprazole). The following adverse effects may occur: occasionally, gastrointestinal disorders (stomach pain, nausea, constipation or diarrhea) may appear, which usually disappear quickly after the dose is reduced or, if necessary, after treatment discontinuation. Darkness of stool: it is frequently observed during treatment and is safe for the patient. Allergic reactions may occur, also.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
FERROLIP

Approved Use

Ferrocholinate is primarily indicated in conditions like iron deficiency anaemia.

Launch Date

1960
Primary
FERROLIP

Approved Use

Treatment of iron deficiency states and iron deficiency anemia in adults and children, for deficient iron absorption, chronic bleeding or in situations where there is an increase of iron demands such as pregnancy or breastfeeding.

Launch Date

1960
Primary
FERROLIP

Approved Use

Treatment of iron deficiency states and iron deficiency anemia in adults and children, for deficient iron absorption, chronic bleeding or in situations where there is an increase of iron demands such as pregnancy or breastfeeding.

Launch Date

1960
PubMed

PubMed

TitleDatePubMed
Patents

Sample Use Guides

In Vivo Use Guide
Curator's Comment: http://www.ndrugs.com/?s=podertonic%20ni%C3%B1os | https://clicks.co.za/chela-fer_iron-supplement-30-tablets/p/44856 | https://www.aemps.gob.es/cima/pdfs/es/ft/54556/54556_ft.pdf
1 tablet (100 mg) daily Adults daily dose is equivalent to 112.6 mg Fe3. Take this medication preferably a few hours before meals. Duration of treatment depends on nature and severity of iron deficiency.
Route of Administration: Oral
In Vitro Use Guide
Unknown
Name Type Language
FERROCHOLINATE
INN   MART.   MI   WHO-DD  
INN  
Official Name English
FERROLIP
Brand Name English
FERROCHOLINATE [MI]
Common Name English
FERROCHOLINATE [MART.]
Common Name English
Ferrocholinate [WHO-DD]
Common Name English
FERRIC CHOLINE CITRATE
Common Name English
IRON CHOLINE CITRATE COMPLEX
Common Name English
ferrocholinate [INN]
Common Name English
(HYDROGEN CITRATO(3-))TRIAQUOIRON, CHOLINE SALT
Common Name English
ETHANAMINIUM, 2-HYDROXY-N,N,N-TRIMETHYL-, (OC-6-44)-TRIAQUA(2-(HYDROXY-.KAPPA.O)-1,2,3-PROPANETRICARBOXYLATO(4-)-.KAPPA.O1,.KAPPA.O2)FERRATE(1-) (1:1)
Common Name English
FRE-SOL
Brand Name English
Classification Tree Code System Code
CFR 21 CFR 172.370
Created by admin on Fri Dec 15 15:56:55 GMT 2023 , Edited by admin on Fri Dec 15 15:56:55 GMT 2023
Code System Code Type Description
NCI_THESAURUS
C1505
Created by admin on Fri Dec 15 15:56:55 GMT 2023 , Edited by admin on Fri Dec 15 15:56:55 GMT 2023
CONCEPT Dietary Supplement
EVMPD
SUB07612MIG
Created by admin on Fri Dec 15 15:56:55 GMT 2023 , Edited by admin on Fri Dec 15 15:56:55 GMT 2023
PRIMARY
MERCK INDEX
m5335
Created by admin on Fri Dec 15 15:56:55 GMT 2023 , Edited by admin on Fri Dec 15 15:56:55 GMT 2023
PRIMARY Merck Index
NCI_THESAURUS
C76836
Created by admin on Fri Dec 15 15:56:55 GMT 2023 , Edited by admin on Fri Dec 15 15:56:55 GMT 2023
PRIMARY
INN
890
Created by admin on Fri Dec 15 15:56:55 GMT 2023 , Edited by admin on Fri Dec 15 15:56:55 GMT 2023
PRIMARY
SMS_ID
100000080961
Created by admin on Fri Dec 15 15:56:55 GMT 2023 , Edited by admin on Fri Dec 15 15:56:55 GMT 2023
PRIMARY
CAS
1336-80-7
Created by admin on Fri Dec 15 15:56:55 GMT 2023 , Edited by admin on Fri Dec 15 15:56:55 GMT 2023
PRIMARY
PUBCHEM
46174080
Created by admin on Fri Dec 15 15:56:55 GMT 2023 , Edited by admin on Fri Dec 15 15:56:55 GMT 2023
PRIMARY
FDA UNII
LWI5ZJ8WVL
Created by admin on Fri Dec 15 15:56:55 GMT 2023 , Edited by admin on Fri Dec 15 15:56:55 GMT 2023
PRIMARY
ECHA (EC/EINECS)
215-649-7
Created by admin on Fri Dec 15 15:56:55 GMT 2023 , Edited by admin on Fri Dec 15 15:56:55 GMT 2023
PRIMARY